Novanta NOVT Medical Solutions — Intangible Amortization
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novanta's medical solutions — intangible amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novanta's medical solutions — intangible amortization?
- Novanta (NOVT) reported medical solutions — intangible amortization of $3.66M in Q1 2026.
- How has Novanta's medical solutions — intangible amortization changed year-over-year?
- Novanta's medical solutions — intangible amortization increased by 16.2% year-over-year, from $3.15M to $3.66M.
- What is the long-term trend for Novanta's medical solutions — intangible amortization?
- Over 3 years (2022 to 2025), Novanta's medical solutions — intangible amortization has grown at a 26.8% compound annual growth rate (CAGR), from $8.68M to $17.71M.
- What does medical solutions — intangible amortization mean?
- This represents the periodic expense recognized for the systematic allocation of the cost of intangible assets, such as patents or customer relationships, over their useful lives. It reflects the consumption of economic value derived from non-physical assets acquired through business combinations or internal development within the segment. Monitoring this helps investors distinguish between cash-based operating expenses and non-cash accounting charges.